The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
A practical guide for the generation of model-based virtual clinical trials
Open accessAbstract
Mathematical modeling has made significant contributions to drug design, development, and optimization. Virtual clinical trials that integrate mathematical models to explore patient heterogeneity and its impact on a variety of therapeutic questions have recently risen in popularity. Here, we outline best practices for creating virtual patients from mathematical models to ultimately implement and execute a virtual clinical trial. In this practical guide, we discuss and provide examples of model design, parameter estimation, parameter sensitivity, model identifiability, and virtual patient cohort creation. Our goal is to help researchers adopt these approaches to further the use of virtual population-based analysis and virtual clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


![FIGURE 3 Example of conducting a virtual clinical trial. (A) Model of oncolytic virotherapy, where uV(t) is the source term of the virus determined by the administration schedule shown in (C) (Wares et al., 2015). (B) Model parameters and initial conditions. (C) Best fit of model to average experimental data when fitting only the parameters and initial conditions specified in (B). (D–F) Profile likelihood curves for the non-fixed parameters. (G) 100 virtual patients that form our virtual population. (H) Virtual clinical trial predicts what percent of virtual patients shrink in response to OV treatment as a function of OV dose [with the protocol fixed as in (C)]. Doses range from experimental dose of 1010 OVs/injection to 90 times the experimental dose.](/paper-figures/619271ef94034b73a05822184fc8aebe/a-practical-guide-for-the-generation-of-model-based-virtual-clinical-trials-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Because virtual population generation and virtual clinical trials depend on parameter distributions rather than point estimates4,5, calibration must quantify uncertainty.”
From Structured Schemas for Provenance-Rich, LLM-Assisted QSP Model Calibration (2026) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Because virtual population generation and virtual clinical trials depend on parameter distributions rather than point estimates [4, 5], calibration must quantify uncertainty.”
From Structured Schemas for Provenance‐Rich, LLM ‐Assisted QSP Model Calibration (2026) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A methodology for performing global uncertainty and sensitivity analysis in systems biology
Marino, S., Hogue, I. B., Ray, C. J., & Kirschner, D. E. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.04.011 · Cited by 2,999
Handbook of Markov Chain Monte Carlo
Brooks, S., Gelman, A., Jones, G., & Meng, X.-L. (2011) · Chapman & Hall/CRC eBooks · doi:10.1201/b10905 · Cited by 2,993
Mckay, M. D., Beckman, R. J., & Conover, W. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10485979 · Cited by 2,833
Raue, A., Kreutz, C., Maiwald, T., Bachmann, J., Schilling, M., Klingmüller, U., & Timmer, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp358 · Cited by 1,442
Approximate Bayesian Computation (ABC) in practice
Csilléry, K., Blum, M. G. B., Gaggiotti, O. E., & François, O. (2010) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2010.04.001 · Cited by 1,302 · cited 1×
“There also exist non-parametric methods for generating posterior distributions for the fi t parameters, including MCMC and the relatively new Approximate Bayesian Computation (ABC) method (Csilléry et al., 2010).”
Mould, D., & Upton, R. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.14 · Cited by 897
Sensitivity and specificity of information criteria
(2019) · doi:10.1093/bib/bbz016 · Cited by 718
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development
Mould, D., & Upton, R. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.4 · Cited by 544
Zhang, X., Trame, M., Lesko, L., & Schmidt, S. (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.6 · Cited by 467 · cited 5×
“This in turn informs model structure, as highlighted in the schematic in Figure 1, and may even lead to recommendations for future experimental design (Zhang et al., 2015).”
InfluentialSensitivity analysis approaches applied to systems biology models
Zi, Z. (2011) · IET Systems Biology · doi:10.1049/iet-syb.2011.0015 · Cited by 384
Research works printed but not linked: 2
- 2022, Project Optimus Reforming the dose optimization and dose selection paradigm in oncology
- Mendes, 2001, Modeling large biological systems from functional genomic data: Parameter estimation, Found. Syst. Biol., 2001, 163
Cited by
Wang, H., Arulraj, T., Ippolito, A., & Popel, A. S. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01188-4 · Cited by 122
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Bollhagen, A., & Bodenmiller, B. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1165 · Cited by 59
Embracing the future of medicine with virtual patients
Wang, K., Parrott, N. J., & Lavé, T. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104322 · Cited by 20
Mathematical Oncology: How Modeling Is Transforming Clinical Decision-Making
Scibilia, K., Gallagher, K., Masud, M. A., Robertson‐Tessi, M., Gatenbee, C., West, J., Llamas, P., Prabhakaran, S., Gallaher, J. A., & Anderson, A. R. A. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0750 · Cited by 19
Porthiyas, J., Nussey, D., Beauchemin, C. A. A., Warren, D. C., Quirouette, C., & Wilkie, K. P. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00409-6 · Cited by 16
Self-citation
Metadata
- Authors
- Craig, M., Gevertz, J. L., Kareva, I., & Wilkie, K. P.
- Affiliations
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- The College of New Jersey (US)
- EMD Serono, Inc. (United States) (US)
- Toronto Metropolitan University (CA)
- Corresponding author
- Craig, Morgan
- Wilkie, Kathleen P.
- Venue
- Frontiers in Systems Biology
- Publisher
- Frontiers Media SA
- Published
- 2023-06-16
- Volume
- 3
- Pages
- 1174647-1174647
- ISSN
- 2674-0702 (ISSN-L)
- PMC
- PMC12341971
- OpenAlex
- W4380988248
- Cited by
- 52
- References
- 60
- Citations by year
- 2026: 21 · 2025: 20 · 2024: 10 · 2023: 1
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Systems Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2018-04546)
- Fonds de Recherche du Québec—Santé
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- virtual clinical trials, virtual patients, mathematical modeling, patient heterogeneity, parameter estimation, parameter sensitivity analysis, model identifiability, virtual patient cohorts, drug development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A practical guide for the generation of model-based virtual clinical trials. https://app.cochat.ai/papers/10.3389/fsysb.2023.1174647
- The paper
- Craig, M., Gevertz, J. L., Kareva, I., & Wilkie, K. P. (2023). A practical guide for the generation of model-based virtual clinical trials. Frontiers in Systems Biology. https://doi.org/10.3389/fsysb.2023.1174647
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.